A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients
Clinical trial NCT02035605 · COMPLETED
Trial details
- NCT number
- NCT02035605
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-20
- Primary completion
- 2017-07-20
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.